Aurora Cannabis (ACB) vs MediWound (MDWD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
MediWound (MDWD) has outperformed Aurora Cannabis (ACB) over the past year, losing 26.7% versus a loss of 27.7%. Over five years, MDWD leads with a -46.2% price change compared with -93.7% for ACB. Aurora Cannabis is the larger company by market cap ($282.4 million vs $165.9 million), about 1.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACB | MDWD |
|---|---|---|
| Share price | $4.46 | $12.85 |
| Market cap | $282.36M | $165.90M |
| 1-day change | -2.83% | -2.28% |
| YTD return | +5.69% | -30.39% |
| 1-year return | -27.71% | -26.74% |
| 5-year return | -93.66% | -46.17% |
| EPS (TTM) | $-0.61 | $-2.17 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.67 | $20.03 |
| 52-week low | $2.56 | $12.52 |
| Distance from 52-week high | -33.08% | -35.85% |
| Average volume | 1.36M | 84.11K |
| Shares outstanding | 63.31M | 12.91M |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ACB vs MDWD FAQ
Which is bigger, Aurora Cannabis or MediWound?
Aurora Cannabis (ACB) is larger, with a market capitalization of $282.36M compared with $165.90M for MediWound (MDWD).
Which stock has performed better over the past year, ACB or MDWD?
MDWD returned -26.74% over the past 12 months, compared with -27.71% for ACB (price return, excluding dividends). Past performance does not predict future results.
Are Aurora Cannabis and MediWound in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.